logo
Select company
Select metric
-50.05%Return on Invested Capital
VS
Market
16
Sector
45
Industry
60
History
20
$ 1.5Close
$ 0.68 - $ 3.23 52-Week Range
Ticker Information

Ticker

FATE

Company Name

FATE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FATE THERAPEUTICS INC - Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FATE - ROIC Historical data
DateInvested CapitalNet Income Common StockReturn on Invested Capital
6/30/2025$ 342.69M$ -171.52M-50.05%
3/31/2025$ 371.74M$ -175.88M-47.31%
12/31/2024$ 403.99M$ -186.26M-46.11%
9/30/2024$ 461.3M$ -178.23M-38.64%
6/30/2024$ 497.54M$ -175.72M-35.32%
3/31/2024$ 528.18M$ -190.05M-35.98%
12/31/2023$ 471.95M$ -160.93M-34.1%
9/30/2023$ 507.73M$ -173.17M-34.11%
6/30/2023$ 544.1M$ -211.56M-38.88%
3/31/2023$ 585.09M$ -234.91M-40.15%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FATE THERAPEUTICS INC's latest trailing twelve months (TTM) ROIC stands at -29.14%.
  • Over the past 5 years, FATE THERAPEUTICS INC's average ROIC has been -36.15%.
  • The median ROIC for FATE THERAPEUTICS INC during this period was -35.99%
  • FATE THERAPEUTICS INC reached its highest ROIC over the past 5 years at -20.53%.
  • The lowest ROIC recorded by FATE THERAPEUTICS INC in the same timeframe -50.05%

FATE THERAPEUTICS INC's ROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROIC Benchmarks
CompanyROIC
CRVO : CERVOMED INC -67.62%TCRX : TSCAN THERAPEUTICS INC -50.02%CUE : CUE BIOPHARMA INC -150.8%SRZN : SURROZEN INC -63.4%KRRO : KORRO BIO INC -57.19%OVID : OVID THERAPEUTICS INC -54.63%ACOG : ALPHA COGNITION INC -62.75%ARMP : ARMATA PHARMACEUTICALS INC -34.53%CBUS : CIBUS INC -84.97%CRBU : CARIBOU BIOSCIENCES INC -85.56%

Definition of Return on Invested Capital

[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for FATE THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -148.58M ] / Inv. Capital [ $ 509.85M ]
(=) ROIC [ -29.14% ]

FATE - Return on Invested Capital, Last 5 years

-50.05%

Minimum

Jun 30, 2025

-20.53%

Maximum

Mar 31, 2021

-36.15%

Average

-35.99%

Median

ROIC Benchmark Analysis

The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.67% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
filtered constituents3.36K
min-46.36%
max48.66%
average0.67%
median3.38%
std15.18%